# Enpro Inc.: financial statements, quarterly NPO · NYSE · CIK 1164863 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/npo.md) · [Financials](/companies/npo/financials.md) · [Filings](/companies/npo/filings.md) · [Insiders](/companies/npo/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/npo/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [251](/filings/0001164863-24-000041.md) | [249 d](/filings/0001164863-25-000009.md) | [258](/filings/0001164863-25-000017.md) | [272](/filings/0001164863-25-000030.md) | [261](/filings/0001628280-25-048610.md) | [258 d](/filings/0001164863-25-000009.md) | [273](/filings/0001628280-26-030295.md) | [288](/filings/0001628280-26-052211.md) | [287](/filings/0001628280-25-048610.md) | [295 d](/filings/0001628280-26-009798.md) | [303](/filings/0001628280-26-030295.md) | [339](/filings/0001628280-26-052211.md) | | Cost of revenue | $m | [151](/filings/0001164863-24-000041.md) | [153 d](/filings/0001628280-26-009798.md) | [151](/filings/0001164863-25-000017.md) | [153](/filings/0001164863-25-000030.md) | [151](/filings/0001628280-25-048610.md) | [149 d](/filings/0001628280-26-009798.md) | [155](/filings/0001628280-26-030295.md) | [163](/filings/0001628280-26-052211.md) | [166](/filings/0001628280-25-048610.md) | [171 d](/filings/0001628280-26-009798.md) | [173](/filings/0001628280-26-030295.md) | [190](/filings/0001628280-26-052211.md) | | Gross profit | $m | [99.6](/filings/0001164863-24-000041.md) | [96.3 d](/filings/0001628280-26-009798.md) | [106](/filings/0001164863-25-000017.md) | [119](/filings/0001164863-25-000030.md) | [110](/filings/0001628280-25-048610.md) | [109 d](/filings/0001628280-26-009798.md) | [118](/filings/0001628280-26-030295.md) | [125](/filings/0001628280-26-052211.md) | [120](/filings/0001628280-25-048610.md) | [124 d](/filings/0001628280-26-009798.md) | [130](/filings/0001628280-26-030295.md) | [149](/filings/0001628280-26-052211.md) | | Selling, general and administrative | $m | [65.6](/filings/0001164863-24-000041.md) | [73.9 d](/filings/0001628280-26-009798.md) | [77.4](/filings/0001164863-25-000017.md) | [70.3](/filings/0001164863-25-000030.md) | [71.7](/filings/0001628280-25-048610.md) | [76.9 d](/filings/0001628280-26-009798.md) | [75.8](/filings/0001628280-26-030295.md) | [79.2](/filings/0001628280-26-052211.md) | [78.9](/filings/0001628280-25-048610.md) | [89.6 d](/filings/0001628280-26-009798.md) | [85.3](/filings/0001628280-26-030295.md) | [89.8](/filings/0001628280-26-052211.md) | | Operating income | $m | [31.9](/filings/0001164863-24-000041.md) | [20.5 d](/filings/0001628280-26-009798.md) | [28.0](/filings/0001164863-25-000017.md) | [48.0](/filings/0001164863-25-000030.md) | [34.1](/filings/0001628280-25-048610.md) | [32.2 d](/filings/0001628280-26-009798.md) | [41.8](/filings/0001628280-26-030295.md) | [45.7](/filings/0001628280-26-052211.md) | [40.9](/filings/0001628280-25-048610.md) | [33.2 d](/filings/0001628280-26-009798.md) | [43.5](/filings/0001628280-26-030295.md) | [57.7](/filings/0001628280-26-052211.md) | | Interest expense | $m | [10.8](/filings/0001164863-23-000061.md) | [10.1 d](/filings/0001164863-24-000015.md) | [10.3](/filings/0001164863-24-000024.md) | [10.7](/filings/0001164863-25-000030.md) | [10.4](/filings/0001628280-25-048610.md) | [9.5 d](/filings/0001628280-26-009798.md) | [9.2](/filings/0001628280-26-030295.md) | [9.0](/filings/0001628280-26-052211.md) | [6.9](/filings/0001628280-25-048610.md) | [8.9 d](/filings/0001628280-26-009798.md) | [9.4](/filings/0001628280-26-030295.md) | [8.7](/filings/0001628280-26-052211.md) | | Income tax | $m | [14.7](/filings/0001164863-24-000041.md) | [13.8 d](/filings/0001628280-26-009798.md) | [1.8](/filings/0001164863-25-000017.md) | [9.7](/filings/0001164863-25-000030.md) | [4.2](/filings/0001628280-25-048610.md) | [5.8 d](/filings/0001628280-26-009798.md) | [7.8](/filings/0001628280-26-030295.md) | [9.1](/filings/0001628280-26-052211.md) | [10.5](/filings/0001628280-25-048610.md) | [(10.3) d](/filings/0001628280-26-009798.md) | [6.5](/filings/0001628280-26-030295.md) | [5.8](/filings/0001628280-26-052211.md) | | Net income | $m | [8.3](/filings/0001164863-24-000041.md) | [(4.9) d](/filings/0001628280-26-009798.md) | [12.5](/filings/0001628280-25-048610.md) | [26.7](/filings/0001628280-25-048610.md) | [19.8](/filings/0001628280-25-048610.md) | [13.9 d](/filings/0001628280-26-009798.md) | [24.5](/filings/0001628280-26-052211.md) | [26.4](/filings/0001628280-26-052211.md) | [21.6](/filings/0001628280-25-048610.md) | [(32.0) d](/filings/0001628280-26-009798.md) | [27.4](/filings/0001628280-26-052211.md) | [27.1](/filings/0001628280-26-052211.md) | | Diluted EPS | $ per share | [0.39](/filings/0001164863-24-000041.md) | not reported | [0.59](/filings/0001164863-25-000017.md) | [1.27](/filings/0001164863-25-000030.md) | [0.94](/filings/0001628280-25-048610.md) | not reported | [1.15](/filings/0001628280-26-030295.md) | [1.25](/filings/0001628280-26-052211.md) | [1.01](/filings/0001628280-25-048610.md) | not reported | [1.29](/filings/0001628280-26-030295.md) | [1.27](/filings/0001628280-26-052211.md) | | Basic EPS | $ per share | [0.40](/filings/0001164863-24-000041.md) | not reported | [0.60](/filings/0001164863-25-000017.md) | [1.27](/filings/0001164863-25-000030.md) | [0.94](/filings/0001628280-25-048610.md) | not reported | [1.16](/filings/0001628280-26-030295.md) | [1.26](/filings/0001628280-26-052211.md) | [1.03](/filings/0001628280-25-048610.md) | not reported | [1.30](/filings/0001628280-26-030295.md) | [1.28](/filings/0001628280-26-052211.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [330](/filings/0001164863-23-000061.md) | [370](/filings/0001164863-25-000009.md) | [164](/filings/0001164863-24-000024.md) | [176](/filings/0001164863-24-000034.md) | [207](/filings/0001164863-24-000041.md) | [236](/filings/0001628280-26-009798.md) | [240](/filings/0001164863-25-000017.md) | [107](/filings/0001164863-25-000030.md) | [133](/filings/0001628280-25-048610.md) | [115](/filings/0001628280-26-052211.md) | [79.2](/filings/0001628280-26-030295.md) | [77.0](/filings/0001628280-26-052211.md) | | Current assets | $m | [637](/filings/0001164863-23-000061.md) | [650](/filings/0001164863-25-000009.md) | [464](/filings/0001164863-24-000024.md) | [481](/filings/0001164863-24-000034.md) | [519](/filings/0001164863-24-000041.md) | [512](/filings/0001628280-26-009798.md) | [544](/filings/0001164863-25-000017.md) | [425](/filings/0001164863-25-000030.md) | [457](/filings/0001628280-25-048610.md) | [438](/filings/0001628280-26-052211.md) | [433](/filings/0001628280-26-030295.md) | [455](/filings/0001628280-26-052211.md) | | Total assets | $m | [2,501](/filings/0001164863-23-000061.md) | [2,500](/filings/0001164863-25-000009.md) | [2,528](/filings/0001164863-24-000024.md) | [2,522](/filings/0001164863-24-000034.md) | [2,534](/filings/0001164863-24-000041.md) | [2,492](/filings/0001628280-26-009798.md) | [2,507](/filings/0001164863-25-000017.md) | [2,375](/filings/0001164863-25-000030.md) | [2,399](/filings/0001628280-25-048610.md) | [2,663](/filings/0001628280-26-052211.md) | [2,636](/filings/0001628280-26-030295.md) | [2,661](/filings/0001628280-26-052211.md) | | Current liabilities | $m | [195](/filings/0001164863-23-000061.md) | [196](/filings/0001164863-25-000009.md) | [179](/filings/0001164863-24-000024.md) | [177](/filings/0001164863-24-000034.md) | [188](/filings/0001164863-24-000041.md) | [198](/filings/0001628280-26-009798.md) | [184](/filings/0001164863-25-000017.md) | [170](/filings/0001164863-25-000030.md) | [187](/filings/0001628280-25-048610.md) | [189](/filings/0001628280-26-052211.md) | [197](/filings/0001628280-26-030295.md) | [200](/filings/0001628280-26-052211.md) | | Total liabilities | $m | [1,076](/filings/0001164863-23-000061.md) | [1,072](/filings/0001164863-25-000009.md) | [1,114](/filings/0001164863-24-000024.md) | [1,092](/filings/0001164863-24-000034.md) | [1,076](/filings/0001164863-24-000041.md) | [1,063](/filings/0001628280-26-009798.md) | [1,045](/filings/0001164863-25-000017.md) | [879](/filings/0001164863-25-000030.md) | [878](/filings/0001628280-25-048610.md) | [1,119](/filings/0001628280-26-052211.md) | [1,073](/filings/0001628280-26-030295.md) | [1,073](/filings/0001628280-26-052211.md) | | Long-term debt | $m | [641](/filings/0001164863-23-000061.md) | [639](/filings/0001164863-25-000009.md) | [670](/filings/0001164863-24-000024.md) | [649](/filings/0001164863-24-000034.md) | [628](/filings/0001164863-24-000041.md) | [624](/filings/0001628280-26-009798.md) | [620](/filings/0001164863-25-000017.md) | [465](/filings/0001164863-25-000030.md) | [445](/filings/0001628280-25-048610.md) | [655](/filings/0001628280-26-052211.md) | [605](/filings/0001628280-26-030295.md) | [575](/filings/0001628280-26-052211.md) | | Current portion of debt | $m | [8.1](/filings/0001164863-23-000061.md) | [8.1](/filings/0001164863-25-000009.md) | [10.1](/filings/0001164863-24-000024.md) | [12.1](/filings/0001164863-24-000034.md) | [14.0](/filings/0001164863-24-000041.md) | [16.0](/filings/0001628280-26-009798.md) | [16.0](/filings/0001164863-25-000017.md) | [0.2](/filings/0001164863-25-000030.md) | [0.2](/filings/0001628280-25-048610.md) | [0.2](/filings/0001628280-26-052211.md) | [0.2](/filings/0001628280-26-030295.md) | [0.2](/filings/0001628280-26-052211.md) | | Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [1,408](/filings/0001164863-24-000041.md) | [1,410](/filings/0001628280-26-009798.md) | [1,414](/filings/0001628280-25-048610.md) | [1,430](/filings/0001628280-25-048610.md) | [1,458](/filings/0001628280-25-048610.md) | [1,429](/filings/0001628280-26-052211.md) | [1,462](/filings/0001628280-26-052211.md) | [1,496](/filings/0001628280-26-052211.md) | [1,521](/filings/0001628280-25-048610.md) | [1,544](/filings/0001628280-26-052211.md) | [1,563](/filings/0001628280-26-052211.md) | [1,587](/filings/0001628280-26-052211.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Short-term borrowings: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [76.3 d](/filings/0001164863-24-000041.md) | [53.6 d](/filings/0001628280-26-009798.md) | [6.3](/filings/0001164863-25-000017.md) | [43.2 d](/filings/0001164863-25-000030.md) | [54.0 d](/filings/0001628280-25-048610.md) | [59.4 d](/filings/0001628280-26-009798.md) | [21.0](/filings/0001628280-26-030295.md) | [52.2 d](/filings/0001628280-26-052211.md) | [65.3 d](/filings/0001628280-25-048610.md) | [62.7 d](/filings/0001628280-26-009798.md) | [39.6](/filings/0001628280-26-030295.md) | [51.3 d](/filings/0001628280-26-052211.md) | | Capital expenditure | $m | [8.8 d](/filings/0001164863-24-000041.md) | [13.2 d](/filings/0001628280-26-009798.md) | [8.2](/filings/0001164863-25-000017.md) | [4.9 d](/filings/0001164863-25-000030.md) | [5.7 d](/filings/0001628280-25-048610.md) | [10.3 d](/filings/0001628280-26-009798.md) | [8.0](/filings/0001628280-26-030295.md) | [9.9 d](/filings/0001628280-26-052211.md) | [11.9 d](/filings/0001628280-25-048610.md) | [12.2 d](/filings/0001628280-26-009798.md) | [12.2](/filings/0001628280-26-030295.md) | [15.6 d](/filings/0001628280-26-052211.md) | | Dividends paid | $m | [6.1 d](/filings/0001164863-24-000041.md) | [6.0 d](/filings/0001628280-26-009798.md) | [6.4](/filings/0001164863-25-000017.md) | [6.3 d](/filings/0001164863-25-000030.md) | [6.3 d](/filings/0001628280-25-048610.md) | [6.3 d](/filings/0001628280-26-009798.md) | [6.6](/filings/0001628280-26-030295.md) | [6.6 d](/filings/0001628280-26-052211.md) | [6.5 d](/filings/0001628280-25-048610.md) | [6.5 d](/filings/0001628280-26-009798.md) | [6.9](/filings/0001628280-26-030295.md) | [6.9 d](/filings/0001628280-26-052211.md) | | Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations, us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: us-gaap:PaymentsOfDividendsCommonStock - Share repurchases: not reported ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [20.9](/filings/0001164863-23-000061.md) | [20.9](/filings/0001164863-24-000024.md) | [20.9](/filings/0001164863-24-000034.md) | [21.0](/filings/0001164863-24-000041.md) | [21.1](/filings/0001164863-25-000017.md) | [21.1](/filings/0001164863-25-000030.md) | [21.1](/filings/0001628280-25-048610.md) | [21.2](/filings/0001628280-26-030295.md) | [21.2](/filings/0001628280-26-052211.md) | [21.3](/filings/0001628280-25-048610.md) | [21.3](/filings/0001628280-26-030295.md) | [21.4](/filings/0001628280-26-052211.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 21,167,681 at 2026-07-23, from the cover of the [10-Q filed 2026-08-04](/filings/0001628280-26-052211.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.